Chronic rhinosinusitis pathogenesis

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 6, 2015, Pages 1442-1453

  Stevens, Whitney W ^a   Lee, Robert J ^b   Schleimer, Robert P ^a   Cohen, Noam A ^b,c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MONELL CHEMICAL SENSES CENTER   (United States)

Author keywords

Chronic rhinosinusitis; epithelial cells; inflammation; microbiome; mucociliary clearance; nasal polyps

Indexed keywords

ANTIINFECTIVE AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; RADICAL; AUTACOID; PEPTIDE;

ADAPTIVE IMMUNITY; ARTICLE; CHRONIC RHINOSINUSITIS; CYSTIC FIBROSIS; EPITHELIUM CELL; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MICROBIOME; MUCOCILIARY CLEARANCE; NOSE POLYP; PRIORITY JOURNAL; ANIMAL; CHRONIC DISEASE; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; RHINITIS; SINUSITIS;

ANIMALS; CHRONIC DISEASE; HUMANS; INFLAMMATION MEDIATORS; MICROBIOTA; MUCOCILIARY CLEARANCE; PEPTIDES; RHINITIS; SINUSITIS;

EID: 84951973395     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.10.009     Document Type: Review

References (155)

1. W.J. Fokkens, V.J. Lund, J. Mullol, C. Bachert, I. Alobid, F. Baroody, and et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012 Rhinol Suppl 23 2012 Mar 3 preceding table of contents, 1-298
2. C.A. Akdis, C. Bachert, C. Cingi, M.S. Dykewicz, P.W. Hellings, R.M. Naclerio, and et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology J Allergy Clin Immunol 131 2013 1479 1490
3. K.A. Smith, R.R. Orlandi, and L. Rudmik Cost of adult chronic rhinosinusitis: a systematic review Laryngoscope 125 2015 1547 1556
4. N.A. Abreu, N.A. Nagalingam, Y. Song, F.C. Roediger, S.D. Pletcher, A.N. Goldberg, and et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis Sci Transl Med 4 2012 151ra24
5. L.M. Feazel, C.E. Robertson, V.R. Ramakrishnan, and D.N. Frank Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis Laryngoscope 122 2012 467 472
6. S. Boase, A. Foreman, E. Cleland, L. Tan, R. Melton-Kreft, H. Pant, and et al. The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection BMC Infect Dis 13 2013 210
7. R. Aurora, D. Chatterjee, J. Hentzleman, G. Prasad, R. Sindwani, and T. Sanford Contrasting the microbiomes from healthy volunteers and patients with chronic rhinosinusitis JAMA Otolaryngol Head Neck Surg 139 2013 1328 1338
8. V.R. Ramakrishnan, L.M. Feazel, S.A. Gitomer, D. Ir, C.E. Robertson, and D.N. Frank The microbiome of the middle meatus in healthy adults PLoS One 8 2013 e85507
9. K. Biswas, M. Hoggard, R. Jain, M.W. Taylor, and R.G. Douglas The nasal microbiota in health and disease: variation within and between subjects Front Microbiol 9 2015 134
10. D.L. Hamilos Host-microbial interactions in patients with chronic rhinosinusitis J Allergy Clin Immunol 133 2014 640 653.e4
11. I.I. Ivanov, L. Frutos Rde, N. Manel, K. Yoshinaga, D.B. Rifkin, R.B. Sartor, and et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine Cell Host Microbe 4 2008 337 349
12. M.R. Knowles, and R.C. Boucher Mucus clearance as a primary innate defense mechanism for mammalian airways J Clin Invest 109 2002 571 577
13. D.A. Groneberg, C. Peiser, Q.T. Dinh, J. Matthias, P.R. Eynott, W. Heppt, and et al. Distribution of respiratory mucin proteins in human nasal mucosa Laryngoscope 113 2003 520 524
14. E.P. Lillehoj, K. Kato, W. Lu, and K.C. Kim Cellular and molecular biology of airway mucins Int Rev Cell Mol Biol 303 2013 139 202
15. G. Lamblin, M. Lhermitte, A. Klein, N. Houdret, A. Scharfman, R. Ramphal, and et al. The carbohydrate diversity of human respiratory mucins: a protection of the underlying mucosa? Am Rev Respir Dis 144 1991 S19 S24
16. T. Feizi, H.C. Gooi, R.A. Childs, J.K. Picard, K. Uemura, L.M. Loomes, and et al. Tumour-associated and differentiation antigens on the carbohydrate moieties of mucin-type glycoproteins Biochem Soc Trans 12 1984 591 596
17. J. Davies, I. Carlstedt, A.K. Nilsson, A. Hakansson, H. Sabharwal, L. van Alphen, and et al. Binding of Haemophilus influenzae to purified mucins from the human respiratory tract Infect Immun 63 1995 2485 2492
18. M.S. Reddy, T.F. Murphy, H.S. Faden, and J.M. Bernstein Middle ear mucin glycoprotein: purification and interaction with nontypable Haemophilus influenzae and Moraxella catarrhalis Otolaryngol Head Neck Surg 116 1997 175 180
19. A. Prince Adhesins and receptors of Pseudomonas aeruginosa associated with infection of the respiratory tract Microb Pathog 13 1992 251 260
20. S.U. Sajjan, and J.F. Forstner Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis Infect Immun 60 1992 1434 1440
21. B. Button, L.H. Cai, C. Ehre, M. Kesimer, D.B. Hill, J.K. Sheehan, and et al. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia Science 337 2012 937 941
22. M.J. Sanderson, and M.A. Sleigh Ciliary activity of cultured rabbit tracheal epithelium: beat pattern and metachrony J Cell Sci 47 1981 331 347
23. R.J. Lee, and J.K. Foskett Ca(2)(+) signaling and fluid secretion by secretory cells of the airway epithelium Cell Calcium 55 2014 325 336
24. A.D. Workman, and N.A. Cohen The effect of drugs and other compounds on the ciliary beat frequency of human respiratory epithelium Am J Rhinol Allergy 28 2014 454 464
25. R.J. Lee, G. Xiong, J.M. Kofonow, B. Chen, A. Lysenko, P. Jiang, and et al. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection J Clin Invest 122 2012 4145 4159
26. K.Q. Zhao, A.T. Cowan, R.J. Lee, N. Goldstein, K. Droguett, B. Chen, and et al. Molecular modulation of airway epithelial ciliary response to sneezing FASEB J 26 2012 3178 3187
27. M.A. Mall, and L.J. Galietta Targeting ion channels in cystic fibrosis J Cyst Fibros 14 2015 561 570
28. E.A. Illing, and B.A. Woodworth Management of the upper airway in cystic fibrosis Curr Opin Pulm Med 20 2014 623 631
29. S. Seshadri, X. Lu, M.R. Purkey, T. Homma, A.W. Choi, R. Carter, and et al. Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis J Allergy Clin Immunol 136 2015 1548 1558
30. A. Ishida, N. Ohta, Y. Suzuki, S. Kakehata, K. Okubo, H. Ikeda, and et al. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis Allergol Int 61 2012 589 595
31. K.M. Adams, V. Abraham, D. Spielman, J.K. Kolls, R.C. Rubenstein, G.E. Conner, and et al. IL-17A induces Pendrin expression and chloride-bicarbonate exchange in human bronchial epithelial cells PLoS One 9 2014 e103263
32. C. Nofziger, S. Dossena, S. Suzuki, K. Izuhara, and M. Paulmichl Pendrin function in airway epithelia Cell Physiol Biochem 28 2011 571 578
33. C. Nofziger, V. Vezzoli, S. Dossena, T. Schonherr, J. Studnicka, J. Nofziger, and et al. STAT6 links IL-4/IL-13 stimulation with pendrin expression in asthma and chronic obstructive pulmonary disease Clin Pharmacol Ther 90 2011 399 405
34. D.A. Gudis, and N.A. Cohen Cilia dysfunction Otolaryngol Clin North Am 43 2010 461 472 vii
35. D. Gudis, K.Q. Zhao, and N.A. Cohen Acquired cilia dysfunction in chronic rhinosinusitis Am J Rhinol Allergy 26 2012 1 6
36. R. Wilson, T. Pitt, G. Taylor, D. Watson, J. MacDermot, D. Sykes, and et al. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro J Clin Invest 79 1987 221 229
37. K.Q. Zhao, N. Goldstein, H. Yang, A.T. Cowan, B. Chen, C. Zheng, and et al. Inherent differences in nasal and tracheal ciliary function in response to Pseudomonas aeruginosa challenge Am J Rhinol Allergy 25 2011 209 213
38. J.C. Shen, E. Cope, B. Chen, J.G. Leid, and N.A. Cohen Regulation of murine sinonasal cilia function by microbial secreted factors Int Forum Allergy Rhinol 2 2012 104 110
39. R. Amitani, G. Taylor, E.N. Elezis, C. Llewellyn-Jones, J. Mitchell, F. Kuze, and et al. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium Infect Immun 63 1995 3266 3271
40. A. Blount, S. Zhang, M. Chestnut, B. Hixon, D. Skinner, E.J. Sorscher, and et al. Transepithelial ion transport is suppressed in hypoxic sinonasal epithelium Laryngoscope 121 2011 1929 1934
41. H.W. Shin, K. Cho, D.W. Kim, D.H. Han, R. Khalmuratova, S.W. Kim, and et al. Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition Am J Respir Crit Care Med 185 2012 944 954
42. C.C. Wei, N.D. Adappa, and N.A. Cohen Use of topical nasal therapies in the management of chronic rhinosinusitis Laryngoscope 123 2013 2347 2359
43. E.H. Ooi, P.J. Wormald, and L.W. Tan Innate immunity in the paranasal sinuses: a review of nasal host defenses Am J Rhinol 22 2008 13 19
44. M. Ramanathan Jr., and A.P. Lane Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis Otolaryngol Head Neck Surg 136 2007 348 356
45. D. Parker, and A. Prince Innate immunity in the respiratory epithelium Am J Respir Cell Mol Biol 45 2011 189 201
46. C.G. Persson Plasma exudation in the airways: mechanisms and function Eur Respir J 4 1991 1268 1274
47. M. Klockars, and S. Reitamo Tissue distribution of lysozyme in man J Histochem Cytochem 23 1975 932 940
48. J.A. Nash, T.N. Ballard, T.E. Weaver, and H.T. Akinbi The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo J Immunol 177 2006 519 526
49. I.R. Prokhorenko, S.V. Zubova, A.Y. Ivanov, and S.V. Grachev Interaction of gram-negative bacteria with cationic proteins: dependence on the surface characteristics of the bacterial cell Int J Gen Med 2 2009 33 38
50. C.M. Woods, D.N. Hooper, E.H. Ooi, L.W. Tan, and A.S. Carney Human lysozyme has fungicidal activity against nasal fungi Am J Rhinol Allergy 25 2011 236 240
51. C.M. Woods, V.S. Lee, D.J. Hussey, S. Irandoust, E.H. Ooi, L.W. Tan, and et al. Lysozyme expression is increased in the sinus mucosa of patients with chronic rhinosinusitis Rhinology 50 2012 147 156
52. M.A. Tewfik, M. Latterich, M.R. DiFalco, and M. Samaha Proteomics of nasal mucus in chronic rhinosinusitis Am J Rhinol 21 2007 680 685
53. V.C. Kalfa, S.L. Spector, T. Ganz, and A.M. Cole Lysozyme levels in the nasal secretions of patients with perennial allergic rhinitis and recurrent sinusitis Ann Allergy Asthma Immunol 93 2004 288 292
54. S. Seshadri, D.C. Lin, M. Rosati, R.G. Carter, J.E. Norton, L. Suh, and et al. Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis Allergy 67 2012 920 928
55. J.R. Clamp, and J.M. Creeth Some non-mucin components of mucus and their possible biological roles Ciba Found Symp 109 1984 121 136
56. D. Legrand Lactoferrin, a key molecule in immune and inflammatory processes Biochem Cell Biol 90 2012 252 268
57. H. Sano, K. Nagai, H. Tsutsumi, and Y. Kuroki Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection Eur J Immunol 33 2003 2894 2902
58. A.J. Psaltis, P.J. Wormald, K.R. Ha, and L.W. Tan Reduced levels of lactoferrin in biofilm-associated chronic rhinosinusitis Laryngoscope 118 2008 895 901
59. B.A. Woodworth, D. Lathers, J.G. Neal, M. Skinner, M. Richardson, M.R. Young, and et al. Immunolocalization of surfactant protein A and D in sinonasal mucosa Am J Rhinol 20 2006 461 465
60. P.H. Chen, and S.Y. Fang The expression of human antimicrobial peptide LL-37 in the human nasal mucosa Am J Rhinol 18 2004 381 385
61. S.T. Kim, H.E. Cha, D.Y. Kim, G.C. Han, Y.S. Chung, Y.J. Lee, and et al. Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease Acta Otolaryngol 123 2003 81 85
62. K. Yamasaki, J. Schauber, A. Coda, H. Lin, R.A. Dorschner, N.M. Schechter, and et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin FASEB J 20 2006 2068 2080
63. S.K. Chennupati, A.G. Chiu, E. Tamashiro, C.A. Banks, M.B. Cohen, B.S. Bleier, and et al. Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis Am J Rhinol Allergy 23 2009 46 51
64. M. Golec Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide Ann Agric Environ Med 14 2007 1 4
65. S. Yim, P. Dhawan, C. Ragunath, S. Christakos, and G. Diamond Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3) J Cyst Fibros 6 2007 403 410
66. B. Sultan, M. Ramanathan Jr., J. Lee, L. May, and A.P. Lane Sinonasal epithelial cells synthesize active vitamin D, augmenting host innate immune function Int Forum Allergy Rhinol 3 2013 26 30
67. S. Hansdottir, and M.M. Monick Vitamin D effects on lung immunity and respiratory diseases Vitam Horm 86 2011 217 237
68. N.A. Akbar, and M.A. Zacharek Vitamin D: immunomodulation of asthma, allergic rhinitis, and chronic rhinosinusitis Curr Opin Otolaryngol Head Neck Surg 19 2011 224 228
69. J.K. Mulligan, B.S. Bleier, B. O'Connell, R.M. Mulligan, C. Wagner, and R.J. Schlosser Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis Clin Exp Immunol 164 2011 312 320
70. P.H. Chen, and S.Y. Fang Expression of human beta-defensin 2 in human nasal mucosa Eur Arch Otorhinolaryngol 261 2004 238 241
71. S.H. Lee, J.E. Kim, H.H. Lim, H.M. Lee, and J.O. Choi Antimicrobial defensin peptides of the human nasal mucosa Ann Otol Rhinol Laryngol 111 2002 135 141
72. J. Harder, U. Meyer-Hoffert, L.M. Teran, L. Schwichtenberg, J. Bartels, S. Maune, and et al. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia Am J Respir Cell Mol Biol 22 2000 714 721
73. D. Proud, S.P. Sanders, and S. Wiehler Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo J Immunol 172 2004 4637 4645
74. B.C. Schutte, and P.B. McCray Jr. [beta]-defensins in lung host defense Annu Rev Physiol 64 2002 709 748
75. M. Vareille, E. Kieninger, M.R. Edwards, and N. Regamey The airway epithelium: soldier in the fight against respiratory viruses Clin Microbiol Rev 24 2011 210 229
76. P.K. Singh, H.P. Jia, K. Wiles, J. Hesselberth, L. Liu, B.A. Conway, and et al. Production of beta-defensins by human airway epithelia Proc Natl Acad Sci U S A 95 1998 14961 14966
77. R. Tarran, B.R. Grubb, D. Parsons, M. Picher, A.J. Hirsh, C.W. Davis, and et al. The CF salt controversy: in vivo observations and therapeutic approaches Mol Cell 8 2001 149 158
78. R. Tarran, and M.R. Redinbo Mammalian short palate lung and nasal epithelial clone 1 (SPLUNC1) in pH-dependent airway hydration Int J Biochem Cell Biol 52 2014 130 135
79. D.D. Tieu, A.T. Peters, R.G. Carter, L. Suh, D.B. Conley, R. Chandra, and et al. Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis J Allergy Clin Immunol 125 2010 667 675
80. S. Seshadri, M. Rosati, D.C. Lin, R.G. Carter, J.E. Norton, A.W. Choi, and et al. Regional differences in the expression of innate host defense molecules in sinonasal mucosa J Allergy Clin Immunol 132 2013 1227 1230.e5
81. T.Q. Do, S. Moshkani, P. Castillo, S. Anunta, A. Pogosyan, A. Cheung, and et al. Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid J Immunol 181 2008 4177 4187
82. J.T. Lee, M. Jansen, A.N. Yilma, A. Nguyen, R. Desharnais, and E. Porter Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis Am J Rhinol Allergy 24 2010 99 104
83. C. Wijkstrom-Frei, S. El-Chemaly, R. Ali-Rachedi, C. Gerson, M.A. Cobas, R. Forteza, and et al. Lactoperoxidase and human airway host defense Am J Respir Cell Mol Biol 29 2003 206 212
84. H. Fischer Mechanisms and function of DUOX in epithelia of the lung Antioxid Redox Signal 11 2009 2453 2465
85. M.A. Fragoso, V. Fernandez, R. Forteza, S.H. Randell, M. Salathe, and G.E. Conner Transcellular thiocyanate transport by human airway epithelia J Physiol 561 2004 183 194
86. G.E. Conner, C. Wijkstrom-Frei, S.H. Randell, V.E. Fernandez, and M. Salathe The lactoperoxidase system links anion transport to host defense in cystic fibrosis FEBS Lett 581 2007 271 278
87. P. Moskwa, D. Lorentzen, K.J. Excoffon, J. Zabner, P.B. McCray Jr., W.M. Nauseef, and et al. A novel host defense system of airways is defective in cystic fibrosis Am J Respir Crit Care Med 175 2007 174 183
88. M. Maniscalco, M. Sofia, and G. Pelaia Nitric oxide in upper airways inflammatory diseases Inflamm Res 56 2007 58 69
89. B. Degano, S. Valmary, E. Serrano, P. Brousset, and J.F. Arnal Expression of nitric oxide synthases in primary ciliary dyskinesia Hum Pathol 42 2011 1855 1861
90. M. Deja, T. Busch, S. Bachmann, K. Riskowski, V. Campean, B. Wiedmann, and et al. Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis Am J Respir Crit Care Med 168 2003 281 286
91. J.A. Knight Review: free radicals, antioxidants, and the immune system Ann Clin Lab Sci 30 2000 145 158
92. S.S. Yoon, R. Coakley, G.W. Lau, S.V. Lymar, B. Gaston, A.C. Karabulut, and et al. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions J Clin Invest 116 2006 436 446
93. T.A. Major, W. Panmanee, J.E. Mortensen, L.D. Gray, N. Hoglen, and D.J. Hassett Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions Antimicrob Agents Chemother 54 2010 4671 4677
94. P.S. Phillips, R. Sacks, G.N. Marcells, N.A. Cohen, and R.J. Harvey Nasal nitric oxide and sinonasal disease: a systematic review of published evidence Otolaryngol Head Neck Surg 144 2011 159 169
95. A.P. Lane, Q.A. Truong-Tran, and R.P. Schleimer Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps Am J Rhinol 20 2006 138 144
96. R.J. Lee, J.M. Kofonow, P.L. Rosen, A.P. Siebert, B. Chen, L. Doghramji, and et al. Bitter and sweet taste receptors regulate human upper respiratory innate immunity J Clin Invest 124 2014 1393 1405
97. D.R. Farquhar, K.J. Kovatch, J.N. Palmer, F.S. Shofer, N.D. Adappa, and N.A. Cohen Phenylthiocarbamide taste sensitivity is associated with sinonasal symptoms in healthy adults Int Forum Allergy Rhinol 5 2015 111 118
98. N.D. Adappa, Z. Zhang, J.N. Palmer, D.W. Kennedy, L. Doghramji, A. Lysenko, and et al. The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery Int Forum Allergy Rhinol 4 2014 3 7
99. R.J. Lee, and N.A. Cohen The emerging role of the bitter taste receptor T2R38 in upper respiratory infection and chronic rhinosinusitis Am J Rhinol Allergy 27 2013 283 286
100. N.D. Adappa, T.J. Howland, J.N. Palmer, D.W. Kennedy, L. Doghramji, A. Lysenko, and et al. Genetics of the taste receptor T2R38 correlates with chronic rhinosinusitis necessitating surgical intervention Int Forum Allergy Rhinol 3 2013 184 187
101. L. Mfuna Endam, A. Filali-Mouhim, P. Boisvert, L.P. Boulet, Y. Bosse, and M. Desrosiers Genetic variations in taste receptors are associated with chronic rhinosinusitis: a replication study Int Forum Allergy Rhinol 4 2014 200 206
102. R.J. Lee, and N.A. Cohen Sinonasal solitary chemosensory cells "taste" the upper respiratory environment to regulate innate immunity Am J Rhinol Allergy 28 2014 366 373
103. R.J. Lee, and N.A. Cohen Bitter and sweet taste receptors in the respiratory epithelium in health and disease J Mol Med (Berl) 92 2014 1235 1244
104. R.J. Lee, and N.A. Cohen Taste receptors in innate immunity Cell Mol Life Sci 72 2015 217 236
105. A.A. Pezzulo, J. Gutierrez, K.S. Duschner, K.S. McConnell, P.J. Taft, S.E. Ernst, and et al. Glucose depletion in the airway surface liquid is essential for sterility of the airways PLoS One 6 2011 e16166
106. K.M. Hatten, J.N. Palmer, R.J. Lee, N.D. Adappa, D.W. Kennedy, and N.A. Cohen Corticosteroid use does not alter nasal mucus glucose in chronic rhinosinusitis Otolaryngol Head Neck Surg 152 2015 1140 1144
107. Z. Zhang, N.D. Adappa, E. Lautenbach, A.G. Chiu, L. Doghramji, T.J. Howland, and et al. The effect of diabetes mellitus on chronic rhinosinusitis and sinus surgery outcome Int Forum Allergy Rhinol 4 2014 315 320
108. U. Kim, S. Wooding, D. Ricci, L.B. Jorde, and D. Drayna Worldwide haplotype diversity and coding sequence variation at human bitter taste receptor loci Hum Mutat 26 2005 199 204
109. M.B. Soyka, P. Wawrzyniak, T. Eiwegger, D. Holzmann, A. Treis, K. Wanke, and et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4 J Allergy Clin Immunol 130 2012 1087 1096.e10
110. K.L. Pothoven, J.E. Norton, K.E. Hulse, L.A. Suh, R.G. Carter, E. Rocci, and et al. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease J Allergy Clin Immunol 136 2015 737 746.e4
111. K. Nomura, K. Obata, T. Keira, R. Miyata, S. Hirakawa, K. Takano, and et al. Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells Respir Res 15 2014 21
112. Z. Malik, E. Roscioli, J. Murphy, J. Ou, A. Bassiouni, P.J. Wormald, and et al. Staphylococcus aureus impairs the airway epithelial barrier in vitro Int Forum Allergy Rhinol 5 2015 551 556
113. C. Rudack, M. Steinhoff, F. Mooren, J. Buddenkotte, K. Becker, C. von Eiff, and et al. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium Clin Exp Allergy 37 2007 1009 1022
114. V.S. Ossovskaya, and N.W. Bunnett Protease-activated receptors: contribution to physiology and disease Physiol Rev 84 2004 579 621
115. S.E. Sobol, P. Christodoulopoulos, J.J. Manoukian, H.P. Hauber, S. Frenkiel, M. Desrosiers, and et al. Cytokine profile of chronic sinusitis in patients with cystic fibrosis Arch Otolaryngol Head Neck Surg 128 2002 1295 1298
116. J.W. Steinke, S.C. Payne, P.G. Chen, J. Negri, E.B. Stelow, and L. Borish Etiology of nasal polyps in cystic fibrosis: not a unimodal disease Ann Otol Rhinol Laryngol 121 2012 579 586
117. D.R. Nagarkar, J.A. Poposki, B.K. Tan, M.R. Comeau, A.T. Peters, K.E. Hulse, and et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis J Allergy Clin Immunol 132 2013 593 600.e12
118. S. Baba, K. Kondo, K. Kanaya, K. Suzukawa, M. Ushio, S. Urata, and et al. Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps Laryngoscope 124 2014 E115 E122
119. M. Lam, L. Hull, R. McLachlan, K. Snidvongs, D. Chin, E. Pratt, and et al. Clinical severity and epithelial endotypes in chronic rhinosinusitis Int Forum Allergy Rhinol 3 2013 121 128
120. D. Miljkovic, A. Bassiouni, C. Cooksley, J. Ou, E. Hauben, P.J. Wormald, and et al. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis Allergy 69 2014 1154 1161
121. M. Lam, L. Hull, A. Imrie, K. Snidvongs, D. Chin, E. Pratt, and et al. Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis Am J Rhinol Allergy 29 2015 175 181
122. H. Olze, U. Forster, T. Zuberbier, L. Morawietz, and E.O. Luger Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3 Rhinology 44 2006 145 150
123. T. Yao, Y. Kojima, A. Koyanagi, H. Yokoi, T. Saito, K. Kawano, and et al. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients Laryngoscope 119 2009 1053 1059
124. T. Van Zele, S. Claeys, P. Gevaert, G. Van Maele, G. Holtappels, P. Van Cauwenberge, and et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators Allergy 61 2006 1280 1289
125. N. Van Bruaene, C.A. Perez-Novo, T.M. Basinski, T. Van Zele, G. Holtappels, N. De Ruyck, and et al. T-cell regulation in chronic paranasal sinus disease J Allergy Clin Immunol 121 2008 1435 1441 e1-3
126. W.W. Stevens, C.J. Ocampo, S. Berdnikovs, M. Sakashita, M. Mahdavinia, L. Suh, and et al. Cytokines in chronic rhinosinusitis: role in eosinophilia and aspirin exacerbated respiratory disease Am J Respir Crit Care Med 192 2015 682 694
127. L. Derycke, S. Eyerich, K. Van Crombruggen, C. Perez-Novo, G. Holtappels, N. Deruyck, and et al. Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps PLoS One 9 2014 e97581
128. N. Zhang, T. Van Zele, C. Perez-Novo, N. Van Bruaene, G. Holtappels, N. DeRuyck, and et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease J Allergy Clin Immunol 122 2008 961 968
129. M. Mahdavinia, L.A. Suh, R.G. Carter, W.W. Stevens, J.E. Norton, A. Kato, and et al. Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia J Allergy Clin Immunol 135 2015 576 579
130. J.M. Mjosberg, S. Trifari, N.K. Crellin, C.P. Peters, C.M. van Drunen, B. Piet, and et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 Nat Immunol 12 2011 1055 1062
131. J.L. Shaw, S. Fakhri, M.J. Citardi, P.C. Porter, D.B. Corry, F. Kheradmand, and et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps Am J Respir Crit Care Med 188 2013 432 439
132. H.H. Walford, S.J. Lund, R.E. Baum, A.A. White, C.M. Bergeron, J. Husseman, and et al. Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness Clin Immunol 155 2014 126 135
133. M. Mahdavinia, R.G. Carter, C.J. Ocampo, W. Stevens, A. Kato, B.K. Tan, and et al. Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity J Allergy Clin Immunol 133 2014 1759 1763
134. T. Takabayashi, A. Kato, A.T. Peters, L.A. Suh, R. Carter, J. Norton, and et al. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps J Allergy Clin Immunol 130 2012 410 420.e5
135. S.M. Hayes, R. Howlin, D.A. Johnston, J.S. Webb, S.C. Clarke, P. Stoodley, and et al. Intracellular residency of Staphylococcus aureus within mast cells in nasal polyps: a novel observation J Allergy Clin Immunol 135 2015 1648 1651
136. F. Lan, N. Zhang, J. Zhang, O. Krysko, Q. Zhang, J. Xian, and et al. Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3 J Allergy Clin Immunol 132 2013 1314 1321
137. H. Pant, A. Hughes, M. Schembri, D. Miljkovic, and D. Krumbiegel CD4(+) and CD8(+) regulatory T cells in chronic rhinosinusitis mucosa Am J Rhinol Allergy 28 2014 e83 e89
138. A. Kato, K.E. Hulse, B.K. Tan, and R.P. Schleimer B-lymphocyte lineage cells and the respiratory system J Allergy Clin Immunol 131 2013 933 958
139. T. Van Zele, P. Gevaert, G. Holtappels, P. van Cauwenberge, and C. Bachert Local immunoglobulin production in nasal polyposis is modulated by superantigens Clin Exp Allergy 37 2007 1840 1847
140. A. Kato, A. Peters, L. Suh, R. Carter, K.E. Harris, R. Chandra, and et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps J Allergy Clin Immunol 121 2008 1385 1392 e1-2
141. K.E. Hulse, J.E. Norton, L. Suh, Q. Zhong, M. Mahdavinia, P. Simon, and et al. Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression J Allergy Clin Immunol 131 2013 1075 1083 e1-7
142. M. Patadia, J. Dixon, D. Conley, R. Chandra, A. Peters, L.A. Suh, and et al. Evaluation of the presence of B-cell attractant chemokines in chronic rhinosinusitis Am J Rhinol Allergy 24 2010 11 16
143. A.T. Peters, A. Kato, N. Zhang, D.B. Conley, L. Suh, B. Tancowny, and et al. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps J Allergy Clin Immunol 125 2010 397 403.e10
144. T. Van Zele, P. Gevaert, J.B. Watelet, G. Claeys, G. Holtappels, C. Claeys, and et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis J Allergy Clin Immunol 114 2004 981 983
145. B.K. Tan, Q.Z. Li, L. Suh, A. Kato, D.B. Conley, R.K. Chandra, and et al. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps J Allergy Clin Immunol 128 2011 1198 1206.e1
146. J.Y. Min, R.C. Kern, K.E. Hulse, R. Chandra, D. Conley, L. Suh, and et al. Evidence for immunoglobulin D in patients with chronic rhinosinusitis [abstract] J Allergy Clin Immunol 133 2013 AB236
147. N. Van Bruaene, L. Derycke, C.A. Perez-Novo, P. Gevaert, G. Holtappels, N. De Ruyck, and et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis J Allergy Clin Immunol 124 2009 253 259 e1-2
148. N. Van Bruaene, P.N. C, K. Van Crombruggen, N. De Ruyck, G. Holtappels, P. Van Cauwenberge, and et al. Inflammation and remodelling patterns in early stage chronic rhinosinusitis Clin Exp Allergy 42 2012 883 890
149. J. Meng, P. Zhou, Y. Liu, F. Liu, X. Yi, S. Liu, and et al. The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling PLoS One 8 2013 e82373
150. A. Zaravinos, G. Soufla, J. Bizakis, and D.A. Spandidos Expression analysis of VEGFA, FGF2, TGFbeta1, EGF and IGF1 in human nasal polyposis Oncol Rep 19 2008 385 391
151. L. Balsalobre, R. Pezato, C. Perez-Novo, M.T. Alves, R.P. Santos, C. Bachert, and et al. Epithelium and stroma from nasal polyp mucosa exhibits inverse expression of TGF-beta1 as compared with healthy nasal mucosa J Otolaryngol Head Neck Surg 42 2013 29
152. Y. Yang, N. Zhang, K.V. Crombruggen, F. Lan, G. Hu, S. Hong, and et al. Differential expression and release of activin A and follistatin in chronic rhinosinusitis with and without nasal polyps PLoS One 10 2015 e0128564
153. M. Yamin, E.H. Holbrook, S.T. Gray, N.Y. Busaba, B. Lovett, and D.L. Hamilos Profibrotic transforming growth factor beta 1 and activin A are increased in nasal polyp tissue and induced in nasal polyp epithelium by cigarette smoke and Toll-like receptor 3 ligation Int Forum Allergy Rhinol 5 2015 573 582
154. T. Takabayashi, A. Kato, A.T. Peters, K.E. Hulse, L.A. Suh, R. Carter, and et al. Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression Am J Respir Crit Care Med 187 2013 49 57
155. T. Takabayashi, A. Kato, A.T. Peters, K.E. Hulse, L.A. Suh, R. Carter, and et al. Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps J Allergy Clin Immunol 132 2013 584 592.e4